Human pluripotent stem cell-derived products: Advances towards robust, scalable and cost-effective manufacturing strategies

Biotechnology Journal

Volumn 10, Issue 1, 2015, Pages 83-95

  Jenkins, Michael J ^a   Farid, Suzanne S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bioprocess economics; Cell therapy; Pluripotent stem cells; Regenerative medicine; Scale up

Indexed keywords

BIOACTIVITY; CELLS; COST EFFECTIVENESS; COSTS; CYTOLOGY; DIAGNOSIS; DISEASE CONTROL; DRUG THERAPY; ECONOMICS; INVESTMENTS;

BIOPROCESSES; CELL THERAPY; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE; SCALE-UP;

STEM CELLS;

AUTOLOGOUS STEM CELL TRANSPLANTATION; BIOPROCESS; CELL DIFFERENTIATION; CELL EXPANSION; CELL FATE; CELL THERAPY; COST EFFECTIVENESS ANALYSIS; HUMAN; INVESTMENT; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; REIMBURSEMENT; REVIEW; BIOREACTOR; BIOTECHNOLOGY; CULTURE TECHNIQUE; REGENERATIVE MEDICINE;

BIOREACTORS; BIOTECHNOLOGY; CELL CULTURE TECHNIQUES; HUMANS; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE;

EID: 84921489092     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201400348     Document Type: Review

References (111)

1. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663-676.
2. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M. et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131, 861-872.
3. Robinton, D. A., Daley, G. Q., The promise of induced pluripotent stem cells in research and therapy. Nature 2012, 481, 295-305.
4. Ebert, A. D., Svendsen, C. N., Human stem cells and drug screening: Opportunities and challenges. Nat. Rev. Drug Discov. 2010, 9, 367-372.
5. Grskovic, M., Javaherian, A., Strulovici, B., Daley, G. Q., Induced pluripotent stem cells -Opportunities for disease modelling and drug discovery. Nat. Rev. Drug Discov. 2011, 10, 915-929.
6. Kiskinis, E., Eggan, K., Progress toward the clinical application of patient-specific pluripotent stem cells. J. Clin. Invest. 2010, 120, 51-59.
7. Wu, S. M., Hochedlinger, K., Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat. Cell Biol. 2011, 13, 497-505.
8. Zeevi-Levin, N., Itskovitz-Eldor, J., Binah, O., Cardiomyocytes derived from human pluripotent stem cells for drug screening. Pharmacol. Ther. 2012, 134, 180-188.
9. Rajamohan, D., Matsa, E., Kalra, S., Crutchley, J. et al., Current status of drug screening and disease modelling in human pluripotent stem cells. Bioessays 2013, 35, 281-298.
10. McKernan, R., McNeish, J., Smith, D., Pharma's developing interest in stem cells. Cell Stem Cell 2010, 6, 517-520.
11. Smith, D. M., Assessing commercial opportunities for autologous and allogeneic cell-based products. Regen. Med. 2012, 7, 721-732.
12. Sivertsson, L., Synnergren, J., Jensen, J., Bjorquist, P., Ingelman-Sundberg, M., Hepatic differentiation and maturation of human embryonic stem cells cultured in a perfused three-dimensional bioreactor. Stem Cells Dev. 2013, 22, 581-594.
13. Schwartz, S. D., Hubschman, J. P., Heilwell, G., Franco-Cardenas, V. et al., Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 2012, 379, 713-720.
14. Idelson, M., Alper, R., Obolensky, A., Ben-Shushan, E. et al., Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 2009, 5, 396-408.
15. Schulz, T. C., Young, H. Y., Agulnick, A. D., Babin, M. J. et al., A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS ONE 2012, 7, e37004.
16. Parker, C., Novel application and requirements for the broad adoption of iPSC-derived cellular materials. World Stem Cells Regenerative Medicine Congress 2014, London, UK, 2014.
17. Kagimoto, H. T. S., Debating the first iPS cell-derived therapy human trial for AMD. World Stem Cells Regenerative Medicine Congress 2014, London, UK, 2014.
18. Placzek, M. R., Chung, I. M., Macedo, H. M., Ismail, S. et al., Stem cell bioprocessing: Fundamentals and principles. J. R. Soc. Interface 2009, 6, 209-232.
19. Mason, C., Dunnill, P., Quantities of cells used for regenerative medicine and some implications for clinicians and bioprocessors. Regen. Med. 2009, 4, 153-157.
20. Simaria, A. S., Hassan, S., Varadaraju, H., Rowley, J. et al., Allogeneic cell therapy bioprocess economics and optimization: Single-use cell expansion technologies. Biotechnol. Bioeng. 2014, 111, 69-83.
21. Lancaster, M. A., Knoblich, J. A., Organogenesis in a dish: Modeling development and disease using organoid technologies. Science 2014, 345, 283.
22. Lancaster, M. A., Renner, M., Martin, C. A., Wenzel, D. et al., Cerebral organoids model human brain development and microcephaly. Nature 2013, 501, 373-379.
23. Takasato, M., Er, P. X., Becroft, M., Vanslambrouck, J. M. et al., Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat. Cell Biol. 2014, 16, 118-126.
24. Nakano, T., Ando, S., Takata, N., Kawada, M. et al., Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 2012, 10, 771-785.
25. Want, A. J., Nienow, A. W., Hewitt, C. J., Coopman, K., Large-scale expansion and exploitation of pluripotent stem cells for regenerative medicine purposes: Beyond the T flask. Regen. Med. 2012, 7, 71-84.
26. Klimanskaya, I., Rosenthal, N., Lanza, R., Derive and conquer: Sourcing and differentiating stem cells for therapeutic applications. Nat. Rev. Drug Discov. 2008, 7, 131-142.
27. Sart, S., Agathos, S. N., Li, Y., Engineering stem cell fate with biochemical and biomechanical properties of microcarriers. Biotechnol. Prog. 2013, 29, 1354-1366.
28. Serra, M., Brito, C., Correia, C., Alves, P. M., Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol. 2012, 30, 350-359.
29. Abbasalizadeh, S., Baharvand, H., Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies. Biotechnol. Adv. 2013, 31, 1600-1623.
30. Chen, A. K., Reuveny, S., Oh, S. K., Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: Achievements and future direction. Biotechnol. Adv. 2013, 31, 1032-1046.
31. Villa-Diaz, L. G., Ross, A. M., Lahann, J., Krebsbach, P. H., Concise review: The evolution of human pluripotent stem cell culture: From feeder cells to synthetic coatings. Stem Cells 2013, 31, 1-7.
32. Sart, S., Schneider, Y. J., Li, Y., Agathos, S. N., Stem cell bioprocess engineering towards cGMP production and clinical applications. Cytotechnology 2014, 66, 709-722.
33. Lund, A. W., Yener, B., Stegemann, J. P., Plopper, G. E., The natural and engineered 3D microenvironment as a regulatory cue during stem cell fate determination. Tissue Eng. B Rev. 2009, 15, 371-380.
34. Lang, H. J., Simplified approach to preliminary cost estimates. Chem. Eng. 1948, 55, 112-113.
35. Pollock, J., Ho, S. V., Farid, S. S., Fed-batch and perfusion culture processes: Economic, environmental, and operational feasibility under uncertainty. Biotechnol. Bioeng. 2013, 110, 206-219.
36. Darkins, C. L., Mandenius, C.-F., Design of large-scale manufacturing of induced pluripotent stem cell derived cardiomyocytes. Chem. Eng. Res. Des. 2014, 92, 1142-1152.
37. Hassan, S., Simaria, A. S., Varadaraju, H., Rowley, J., Farid, S. S., A tool to predict the economic benefit of alternative technologies for allogeneic cell therapy manufacture at commercial scale. 245th American Chemical Society (ACS) National Meeting, New Orleans, Louisiana, USA, 2013.
38. Farid, S. S., Hassan, S., Simaria, A. S., Varadaraju, H., Warren, K., Can the cell therapy sector achieve acceptable cost of goods at the commercial scale? 20th ISCT Annual Meeting, Paris, France, 2014.
39. Veraitch, F. S., Scott, R., Wong, J. W., Lye, G. J., Mason, C., The impact of manual processing on the expansion and directed differentiation of embryonic stem cells. Biotechnol. Bioeng. 2008, 99, 1216-1229.
40. Farid, S. S., Washbrook, J., Titchener-Hooker, N. J., Decision-support tool for assessing biomanufacturing strategies under uncertainty: Stainless steel versus disposable equipment for clinical trial material preparation. Biotechnol. Prog. 2005, 21, 486-497.
41. Lim, A. C., Washbrook, J., Titchener-Hooker, N. J., Farid, S. S., A computer-aided approach to compare the production economics of fed-batch and perfusion culture under uncertainty. Biotechnol. Bioeng. 2006, 93, 687-697.
42. Eiselleova, L., Peterkova, I., Neradil, J., Slaninova, I. et al., Comparative study of mouse and human feeder cells for human embryonic stem cells. Int. J. Dev. Biol. 2008, 52, 353-363.
43. Rowley, J., Abraham, E., Campbell, A., Brandwein, H., Oh, S., Meeting lot-size challenges of manufacturing adherent cells for therapy. BioProcess Int. 2012, 10, 16-22.
44. Rodrigues, C. A. V., Fernandes, T. G., Diogo, M. M., da Silva, C. L., Cabral, J. M. S., Stem cell cultivation in bioreactors. Biotechnol. Adv. 2011, 29, 815-829.
45. Brandenburger, R., Burger, S., Campbell, A., Fong, T. et al., Cell therapy bioprocessing. BioProcess Int. 2011, 9, 30-37.
46. Thomas, R. J., Anderson, D., Chandra, A., Smith, N. M. et al., Automated, scalable culture of human embryonic stem cells in feeder-free conditions. Biotechnol. Bioeng. 2009, 102, 1636-1644.
47. Oh, S. K. W., Chen, A. K., Mok, Y., Chen, X. et al., Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res. 2009, 2, 219-230.
48. Gerecht-Nir, S., Cohen, S., Itskovitz-Eldor, J., Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol. Bioeng. 2004, 86, 493-502.
49. Olmer, R., Lange, A., Selzer, S., Kasper, C. et al., Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. Tissue Eng. C Methods 2012, 18, 772-784.
50. Chisti, Y., Hydrodynamic damage to animal cells. Crit. Rev. Biotechnol. 2001, 21, 67-110.
51. Leung, H. W., Chen, A., Choo, A. B., Reuveny, S., Oh, S. K., Agitation can induce differentiation of human pluripotent stem cells in microcarrier cultures. Tissue Eng. C Methods 2011, 17, 165-172.
52. Chen, G., Gulbranson, D. R., Hou, Z., Bolin, J. M. et al., Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 2011, 8, 424-429.
53. Wang, Y., Chou, B. K., Dowey, S., He, C. et al., Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions. Stem Cell Res. 2013, 11, 1103-1116.
54. Marinho, P. A., Vareschini, D. T., Gomes, I. C., Paulsen Bda, S. et al., Xeno-free production of human embryonic stem cells in stirred microcarrier systems using a novel animal/human-component-free medium. Tissue Eng. C Methods 2013, 19, 146-155.
55. Phillips, B. W., Horne, R., Lay, T. S., Rust, W. L. et al., Attachment and growth of human embryonic stem cells on microcarriers. J. Biotechnol. 2008, 138, 24-32.
56. Fernandes, A. M., Marinho, P. A., Sartore, R. C., Paulsen, B. S. et al., Successful scale-up of human embryonic stem cell production in a stirred microcarrier culture system. Braz. J. Med. Biol. Res. 2009, 42, 515-522.
57. Serra, M., Brito, C., Sousa, M. F., Jensen, J. et al., Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. J. Biotechnol. 2010, 148, 208-215.
58. Chen, A. K., Chen, X., Lim, Y. M., Reuveny, S., Oh, S. K., Inhibition of ROCK-myosin II signaling pathway enables culturing of human pluripotent stem cells on microcarriers without extracellular matrix coating. Tissue Eng. C Methods 2014, 20, 227-238.
59. Rodin, S., Domogatskaya, A., Strom, S., Hansson, E. M. et al., Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat. Biotechnol. 2010, 28, 611-615.
60. Chen, A. K., Chen, X., Choo, A. B., Reuveny, S., Oh, S. K., Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells. Stem Cell Res. 2011, 7, 97-111.
61. Melkoumian, Z., Weber, J. L., Weber, D. M., Fadeev, A. G. et al., Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat. Biotechnol. 2010, 28, 606-610.
62. Villa-Diaz, L. G., Nandivada, H., Ding, J., Nogueira-de-Souza, N. C. et al., Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat. Biotechnol. 2010, 28, 581-583.
63. Fan, Y., Hsiung, M., Cheng, C., Tzanakakis, E. S., Facile engineering of xeno-free microcarriers for the scalable cultivation of human pluripotent stem cells in stirred suspension. Tissue Eng. A 2014, 20, 588-599.
64. Tamura, A., Kobayashi, J., Yamato, M., Okano, T., Temperature-responsive poly(N-isopropylacrylamide)-grafted microcarriers for large-scale non-invasive harvest of anchorage-dependent cells. Biomaterials 2012, 33, 3803-3812.
65. Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A. et al., A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 2007, 25, 681-686.
66. Krawetz, R., Taiani, J. T., Liu, S., Meng, G. et al., Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. Tissue Eng. C Methods 2010, 16, 573-582.
67. Ungrin, M. D., Clarke, G., Yin, T., Niebrugge, S. et al., Rational bioprocess design for human pluripotent stem cell expansion and endoderm differentiation based on cellular dynamics. Biotechnol. Bioeng. 2012, 109, 853-866.
68. Abbasalizadeh, S., Larijani, M. R., Samadian, A., Baharvand, H., Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor. Tissue Eng. C Methods 2012, 18, 831-851.
69. Chen, V. C., Couture, S. M., Ye, J., Lin, Z. et al., Scalable GMP compliant suspension culture system for human ES cells. Stem Cell Res. 2012, 8, 388-402.
70. Zweigerdt, R., Olmer, R., Singh, H., Haverich, A., Martin, U., Scalable expansion of human pluripotent stem cells in suspension culture. Nat. Protoc. 2011, 6, 689-700.
71. Amit, M., Laevsky, I., Miropolsky, Y., Shariki, K. et al., Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat. Protoc. 2011, 6, 572-579.
72. Olmer, R., Haase, A., Merkert, S., Cui, W. et al., Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res. 2010, 5, 51-64.
73. Singh, H., Mok, P., Balakrishnan, T., Rahmat, S. N., Zweigerdt, R., Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res. 2010, 4, 165-179.
74. Lock, L. T., Tzanakakis, E. S., Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. Tissue Eng. A 2009, 15, 2051-2063.
75. Fridley, K. M., Kinney, M. A., McDevitt, T. C., Hydrodynamic modulation of pluripotent stem cells. Stem Cell Res. Ther. 2012, 3, 45.
76. Kehoe, D. E., Jing, D. H., Lock, L. T., Tzanakakis, E. S., Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng. A 2010, 16, 405-421.
77. Bardy, J., Chen, A. K., Lim, Y. M., Wu, S. et al., Microcarrier suspension cultures for high-density expansion and differentiation of human pluripotent stem cells to neural progenitor cells. Tissue Eng. C Methods 2013, 19, 166-180.
78. Mordwinkin, N., Burridge, P., Wu, J., A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards. J. Cardiovasc. Transl. Res. 2013, 6, 22-30.
79. Karumbayaram, S., Novitch, B. G., Patterson, M., Umbach, J. A. et al., Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 2009, 27, 806-811.
80. Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H. et al., Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 2009, 104, e30-e41.
81. Ghodsizadeh, A., Taei, A., Totonchi, M., Seifinejad, A. et al., Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells. Stem Cell Rev. 2010, 6, 622-632.
82. Sullivan, G. J., Hay, D. C., Park, I. H., Fletcher, J. et al., Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 2010, 51, 329-335.
83. Martinez, Y., Dubois-Dauphin, M., Krause, K. H., Generation and applications of human pluripotent stem cells induced into neural lineages and neural tissues. Front. Physiol. 2012, 3, 47.
84. Surmacz, B., Fox, H., Gutteridge, A., Lubitz, S., Whiting, P., Directing differentiation of human embryonic stem cells toward anterior neural ectoderm using small molecules. Stem Cells 2012, 30, 1875-1884.
85. Zhu, S., Wei, W., Ding, S., Chemical strategies for stem cell biology and regenerative medicine. Annu. Rev. Biomed. Eng. 2011, 13, 73-90.
86. Li, W., Jiang, K., Ding, S., Concise review: A chemical approach to control cell fate and function. Stem Cells 2012, 30, 61-68.
87. Burridge, P. W., Thompson, S., Millrod, M. A., Weinberg, S. et al., A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS ONE 2011, e18293.
88. Chambers, S. M., Qi, Y., Mica, Y., Lee, G. et al., Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat. Biotechnol. 2012, 30, 715-720.
89. Liu, Q., Pedersen, O. Z., Peng, J., Couture, L. A. et al., Optimizing dopaminergic differentiation of pluripotent stem cells for the manufacture of dopaminergic neurons for transplantation. Cytotherapy 2013, 15, 999-1010.
90. Diekmann, U., Lenzen, S., Naujok, O., A reliable and efficient protocol for human pluripotent stem cell differentiation into the definitive endoderm based on dispersed single cells. Stem Cells Dev. 2014, DOI:10.1089/scd.2014.0143.
91. Lippmann, E. S., Estevez-Silva, M. C., Ashton, R. S., Defined human pluripotent stem cell culture enables highly efficient neuroepithelium derivation without small molecule inhibitors. Stem Cells 2014, 32, 1032-1042.
92. Lu, S. J., Kelley, T., Feng, Q., Chen, A. et al., 3D microcarrier system for efficient differentiation of human pluripotent stem cells into hematopoietic cells without feeders and serum [corrected]. Regen. Med. 2013, 8, 413-424.
93. Lecina, M., Ting, S., Choo, A., Reuveny, S., Oh, S., Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. Tissue Eng. C Methods 2010, 16, 1609-1619.
94. Vosough, M., Omidinia, E., Kadivar, M., Shokrgozar, M. A. et al., Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture. Stem Cells Dev. 2013, 22, 2693-2705.
95. Zwi-Dantsis, L., Mizrahi, I., Arbel, G., Gepstein, A., Gepstein, L., Scalable production of cardiomyocytes derived from c-Myc free induced pluripotent stem cells. Tissue Eng. A 2011, 17, 1027-1037.
96. Niebruegge, S., Nehring, A., Bar, H., Schroeder, M. et al., Cardiomyocyte production in mass suspension culture: Embryonic stem cells as a source for great amounts of functional cardiomyocytes. Tissue Eng. A 2008, 14, 1591-1601.
97. Weng, Z., Kong, C. W., Ren, L., Karakikes, I. et al., A simple, cost-effective but highly efficient system for deriving ventricular cardiomyocytes from human pluripotent stem cells. Stem Cells Dev. 2014, 23, 1704-1716.
98. Bratt-Leal, A. M., Nguyen, A. H., Hammersmith, K. A., Singh, A., McDevitt, T. C., A microparticle approach to morphogen delivery within pluripotent stem cell aggregates. Biomaterials 2013, 34, 7227-7235.
99. Wolfe, R. P., Leleux, J., Nerem, R. M., Ahsan, T., Effects of shear stress on germ lineage specification of embryonic stem cells. Integr. Biol. (Camb.) 2012, 4, 1263-1273.
100. Wolfe, R. P., Ahsan, T., Shear stress during early embryonic stem cell differentiation promotes hematopoietic and endothelial phenotypes. Biotechnol. Bioeng. 2013, 110, 1231-1242.
101. Ahsan, T., Nerem, R. M., Fluid shear stress promotes an endothelial-like phenotype during the early differentiation of embryonic stem cells. Tissue Eng. A 2010, 16, 3547-3553.
102. Adamo, L., Naveiras, O., Wenzel, P. L., McKinney-Freeman, S. et al., Biomechanical forces promote embryonic haematopoiesis. Nature 2009, 459, 1131-1135.
103. Bae, D., Mondragon-Teran, P., Hernandez, D., Ruban, L. et al., Hypoxia enhances the generation of retinal progenitor cells from human induced pluripotent and embryonic stem cells. Stem Cells Dev. 2012, 21, 1344-1355.
104. Cimetta, E., Figallo, E., Cannizzaro, C., Elvassore, N., Vunjak-Novakovic, G., Micro-bioreactor arrays for controlling cellular environments: Design principles for human embryonic stem cell applications. Methods 2009, 47, 81-89.
105. Wang, D., Bodovitz, S., Single cell analysis: The new frontier in 'omics'. Trends Biotechnol. 2010, 28, 281-290.
106. Prabhakarpandian, B., Shen, M. C., Pant, K., Kiani, M. F., Microfluidic devices for modeling cell-cell and particle-cell interactions in the microvasculature. Microvasc. Res. 2011, 82, 210-220.
107. Reichen, M., Macown, R. J., Jaccard, N., Super, A. et al., Microfabricated modular scale-down device for regenerative medicine process development. PLoS ONE 2012, 7, e52246.
108. Macown, R. J., Veraitch, F. S., Szita, N., Robust, microfabricated culture devices with improved control over the soluble microenvironment for the culture of embryonic stem cells. Biotechnol. J. 2014, 9, 805-813.
109. Fluri, D. A., Tonge, P. D., Song, H., Baptista, R. P. et al., Derivation, expansion and differentiation of induced pluripotent stem cells in continuous suspension cultures. Nat. Methods 2012, 9, 509-516.
110. Baptista, R. P., Fluri, D. A., Zandstra, P. W., High density continuous production of murine pluripotent cells in an acoustic perfused bioreactor at different oxygen concentrations. Biotechnol. Bioeng. 2013, 110, 648-655.
111. Nistor, G. I., Totoiu, M. O., Haque, N., Carpenter, M. K., Keirstead, H. S., Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 2005, 49, 385-396.